RUNX1T1 and acute myeloid leukemia: Validation of these findings in a mammalian model has shown that treatment of AML cells harboring the (t8;21) translocation and constitutively expressing AML1-ETO with calpain inhibitors resulted in decreased cell viability and clonogenicity.